Compile Data Set for Download or QSAR
maximum 50k data
Found 37 Enz. Inhib. hit(s) with all data for entry = 247
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-22(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247032(US9701663, 47 | rac.-cis-1-((-5-methyl-1-(phenylsu...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247032(US9701663, 47 | rac.-cis-1-((-5-methyl-1-(phenylsu...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247032(US9701663, 47 | rac.-cis-1-((-5-methyl-1-(phenylsu...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247033(US9701663, 48 | rac.-trans-1-((-5-methyl-1-(phenyl...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247033(US9701663, 48 | rac.-trans-1-((-5-methyl-1-(phenyl...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247033(US9701663, 48 | rac.-trans-1-((-5-methyl-1-(phenyl...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: >1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-22(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: >1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17A(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-17F(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-22(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-21(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-22(Homo sapiens (Human))
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: <1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent